The stratified analysis also revealed that high PLCE1 expression increased the risk of recurrence and death in patients who were male and had early-stage BCLC, a single tumor, cirrhosis, and AFP level > 300 ng/ml. The gene discussed is PLCE1; the disease is Cirrhosis.